

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 6.82646168 |
| 2 | protein carboxylation (GO:0018214) | 6.41274993 |
| 3 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.41274993 |
| 4 | regulation of fibrinolysis (GO:0051917) | 6.02278295 |
| 5 | low-density lipoprotein particle remodeling (GO:0034374) | 5.85847008 |
| 6 | plasma lipoprotein particle assembly (GO:0034377) | 5.70442131 |
| 7 | plasma lipoprotein particle remodeling (GO:0034369) | 5.53875510 |
| 8 | protein-lipid complex remodeling (GO:0034368) | 5.53875510 |
| 9 | macromolecular complex remodeling (GO:0034367) | 5.53875510 |
| 10 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.50391201 |
| 11 | regulation of protein activation cascade (GO:2000257) | 5.41954275 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 5.34747052 |
| 13 | regulation of complement activation (GO:0030449) | 5.31089783 |
| 14 | protein-lipid complex assembly (GO:0065005) | 5.12025209 |
| 15 | regulation of apoptotic cell clearance (GO:2000425) | 5.10342647 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07985993 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.02189158 |
| 18 | plasma lipoprotein particle organization (GO:0071827) | 4.99137923 |
| 19 | cholesterol efflux (GO:0033344) | 4.94853091 |
| 20 | regulation of plasminogen activation (GO:0010755) | 4.94760890 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 4.92865702 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92110753 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92110753 |
| 24 | DNA deamination (GO:0045006) | 4.84858442 |
| 25 | pinocytosis (GO:0006907) | 4.76097960 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.75914259 |
| 27 | protein-lipid complex subunit organization (GO:0071825) | 4.71595615 |
| 28 | negative regulation of sterol transport (GO:0032372) | 4.52400738 |
| 29 | negative regulation of cholesterol transport (GO:0032375) | 4.52400738 |
| 30 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.50814904 |
| 31 | ribosomal small subunit assembly (GO:0000028) | 4.37925295 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 4.37641877 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35913047 |
| 34 | blood coagulation, intrinsic pathway (GO:0007597) | 4.32549636 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.26538587 |
| 36 | L-phenylalanine catabolic process (GO:0006559) | 4.23843177 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.23843177 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.18336509 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.17186565 |
| 40 | regulation of cholesterol homeostasis (GO:2000188) | 4.12403448 |
| 41 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.02688415 |
| 42 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.02688415 |
| 43 | phospholipid efflux (GO:0033700) | 4.00716728 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 4.00259045 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.00259045 |
| 46 | positive regulation of extracellular matrix organization (GO:1903055) | 3.88349366 |
| 47 | acute-phase response (GO:0006953) | 3.87395991 |
| 48 | fibrinolysis (GO:0042730) | 3.83931105 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76940385 |
| 50 | regulation of humoral immune response (GO:0002920) | 3.57496514 |
| 51 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.56808609 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52393289 |
| 53 | protein activation cascade (GO:0072376) | 3.51570759 |
| 54 | imidazole-containing compound metabolic process (GO:0052803) | 3.49950472 |
| 55 | leukocyte aggregation (GO:0070486) | 3.47855131 |
| 56 | negative regulation of hemostasis (GO:1900047) | 3.46971899 |
| 57 | negative regulation of blood coagulation (GO:0030195) | 3.46971899 |
| 58 | positive regulation of hemostasis (GO:1900048) | 3.46380709 |
| 59 | positive regulation of blood coagulation (GO:0030194) | 3.46380709 |
| 60 | lipoprotein metabolic process (GO:0042157) | 3.43800883 |
| 61 | complement activation, classical pathway (GO:0006958) | 3.40981467 |
| 62 | interferon-gamma production (GO:0032609) | 3.40181155 |
| 63 | positive regulation of phagocytosis (GO:0050766) | 3.36391512 |
| 64 | viral transcription (GO:0019083) | 3.31022465 |
| 65 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.29769365 |
| 66 | intestinal absorption (GO:0050892) | 3.25641301 |
| 67 | glutamate metabolic process (GO:0006536) | 3.22785121 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 3.22709585 |
| 69 | low-density lipoprotein particle clearance (GO:0034383) | 3.22546773 |
| 70 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.19854950 |
| 71 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.19521590 |
| 72 | regulation of superoxide anion generation (GO:0032928) | 3.18715133 |
| 73 | protein targeting to ER (GO:0045047) | 3.18415703 |
| 74 | cotranslational protein targeting to membrane (GO:0006613) | 3.16511041 |
| 75 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.14976138 |
| 76 | negative regulation of coagulation (GO:0050819) | 3.12937504 |
| 77 | IMP biosynthetic process (GO:0006188) | 3.12671157 |
| 78 | cholesterol homeostasis (GO:0042632) | 3.10769125 |
| 79 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.10653729 |
| 80 | translational termination (GO:0006415) | 3.10476074 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.10364091 |
| 82 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.09091382 |
| 83 | complement activation (GO:0006956) | 3.08219292 |
| 84 | sterol homeostasis (GO:0055092) | 3.07496403 |
| 85 | regulation of B cell differentiation (GO:0045577) | 3.06941509 |
| 86 | cholesterol transport (GO:0030301) | 3.05002300 |
| 87 | sterol transport (GO:0015918) | 3.05002300 |
| 88 | regulation of phagocytosis (GO:0050764) | 3.03313374 |
| 89 | urea cycle (GO:0000050) | 3.01606480 |
| 90 | mannose metabolic process (GO:0006013) | 3.00975020 |
| 91 | urea metabolic process (GO:0019627) | 2.99905975 |
| 92 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.98933049 |
| 93 | proline biosynthetic process (GO:0006561) | 2.98914076 |
| 94 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.98757891 |
| 95 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.98757891 |
| 96 | ribosomal small subunit biogenesis (GO:0042274) | 2.98654400 |
| 97 | regulation of extracellular matrix organization (GO:1903053) | 2.98321270 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98302379 |
| 99 | protein localization to endoplasmic reticulum (GO:0070972) | 2.98125217 |
| 100 | diacylglycerol metabolic process (GO:0046339) | 2.94439880 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 2.92874172 |
| 102 | COPI coating of Golgi vesicle (GO:0048205) | 2.92874172 |
| 103 | positive regulation of steroid metabolic process (GO:0045940) | 2.91383431 |
| 104 | negative regulation of wound healing (GO:0061045) | 2.91051934 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91046733 |
| 106 | signal peptide processing (GO:0006465) | 2.90219454 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 2.89999085 |
| 108 | translational elongation (GO:0006414) | 2.89692700 |
| 109 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.89658018 |
| 110 | acylglycerol homeostasis (GO:0055090) | 2.87460850 |
| 111 | triglyceride homeostasis (GO:0070328) | 2.87460850 |
| 112 | response to interleukin-15 (GO:0070672) | 2.87138335 |
| 113 | acute inflammatory response (GO:0002526) | 2.85553371 |
| 114 | positive thymic T cell selection (GO:0045059) | 2.83946744 |
| 115 | oligosaccharide catabolic process (GO:0009313) | 2.83496968 |
| 116 | positive regulation of B cell differentiation (GO:0045579) | 2.83157068 |
| 117 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81408574 |
| 118 | negative regulation of digestive system process (GO:0060457) | 2.80106514 |
| 119 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.78788921 |
| 120 | formation of translation preinitiation complex (GO:0001731) | 2.77923618 |
| 121 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.76190413 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.73998198 |
| 123 | nitrogen cycle metabolic process (GO:0071941) | 2.72348786 |
| 124 | DNA strand elongation (GO:0022616) | 2.71985214 |
| 125 | negative T cell selection (GO:0043383) | 2.71702554 |
| 126 | cellular response to interleukin-15 (GO:0071350) | 2.68898325 |
| 127 | IMP metabolic process (GO:0046040) | 2.67930651 |
| 128 | GDP-mannose metabolic process (GO:0019673) | 2.66435503 |
| 129 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64481240 |
| 130 | ribosome biogenesis (GO:0042254) | 2.63768620 |
| 131 | negative regulation of lipid transport (GO:0032369) | 2.62255598 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 2.60711364 |
| 133 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.60037369 |
| 134 | regulation of lipoprotein particle clearance (GO:0010984) | 2.59040718 |
| 135 | telomere maintenance via recombination (GO:0000722) | 2.57856713 |
| 136 | regulation of cholesterol storage (GO:0010885) | 2.56969468 |
| 137 | regulation of monocyte differentiation (GO:0045655) | 2.55865653 |
| 138 | negative regulation of complement activation (GO:0045916) | 2.55833260 |
| 139 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55689648 |
| 140 | mast cell activation (GO:0045576) | 2.55227069 |
| 141 | negative regulation of phagocytosis (GO:0050765) | 2.54479399 |
| 142 | cellular response to interleukin-4 (GO:0071353) | 2.54041362 |
| 143 | glyoxylate metabolic process (GO:0046487) | 2.52865799 |
| 144 | protein retention in ER lumen (GO:0006621) | 2.52624834 |
| 145 | hyaluronan metabolic process (GO:0030212) | 2.52295185 |
| 146 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.51899442 |
| 147 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.51196631 |
| 148 | regulation of cholesterol metabolic process (GO:0090181) | 2.50849576 |
| 149 | negative regulation of humoral immune response (GO:0002921) | 2.50489837 |
| 150 | translational initiation (GO:0006413) | 2.50043142 |
| 151 | aromatic amino acid family catabolic process (GO:0009074) | 2.48442098 |
| 152 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.46965120 |
| 153 | lipid homeostasis (GO:0055088) | 2.46864092 |
| 154 | immunoglobulin mediated immune response (GO:0016064) | 2.45689168 |
| 155 | positive regulation of chemokine secretion (GO:0090197) | 2.44770522 |
| 156 | negative regulation of cell killing (GO:0031342) | 2.44301929 |
| 157 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.44301929 |
| 158 | viral life cycle (GO:0019058) | 2.42770637 |
| 159 | thymic T cell selection (GO:0045061) | 2.42057048 |
| 160 | pseudouridine synthesis (GO:0001522) | 2.41593283 |
| 161 | ribosomal large subunit biogenesis (GO:0042273) | 2.38650425 |
| 162 | T cell migration (GO:0072678) | 2.37314311 |
| 163 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.37073812 |
| 164 | maturation of SSU-rRNA (GO:0030490) | 2.36512331 |
| 165 | sequestering of actin monomers (GO:0042989) | 2.35562863 |
| 166 | regulation of necroptotic process (GO:0060544) | 2.34794500 |
| 167 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.34651312 |
| 168 | cellular response to interferon-beta (GO:0035458) | 2.32696376 |
| 169 | B cell receptor signaling pathway (GO:0050853) | 2.32533006 |
| 170 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.31038551 |
| 171 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.31038551 |
| 172 | negative regulation of interleukin-12 production (GO:0032695) | 2.28125827 |
| 173 | telomere maintenance via telomere lengthening (GO:0010833) | 2.28037312 |
| 174 | mitotic recombination (GO:0006312) | 2.27538578 |
| 175 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.27475640 |
| 176 | natural killer cell activation (GO:0030101) | 2.27271806 |
| 177 | proline metabolic process (GO:0006560) | 2.26841369 |
| 178 | B cell mediated immunity (GO:0019724) | 2.25523597 |
| 179 | DNA replication initiation (GO:0006270) | 2.25097805 |
| 180 | response to type I interferon (GO:0034340) | 2.24736541 |
| 181 | mature B cell differentiation involved in immune response (GO:0002313) | 2.24691648 |
| 182 | T cell homeostasis (GO:0043029) | 2.24686827 |
| 183 | T cell receptor signaling pathway (GO:0050852) | 2.24255098 |
| 184 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.23954597 |
| 185 | response to interferon-beta (GO:0035456) | 2.23702094 |
| 186 | positive regulation of protein deacetylation (GO:0090312) | 2.23023415 |
| 187 | regulation of translation in response to stress (GO:0043555) | 2.22774295 |
| 188 | DNA unwinding involved in DNA replication (GO:0006268) | 2.22025980 |
| 189 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.21767878 |
| 190 | valine metabolic process (GO:0006573) | 2.21552164 |
| 191 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.20975438 |
| 192 | cellular response to type I interferon (GO:0071357) | 2.20690028 |
| 193 | type I interferon signaling pathway (GO:0060337) | 2.20690028 |
| 194 | lymph node development (GO:0048535) | 2.20403122 |
| 195 | regulation of response to interferon-gamma (GO:0060330) | 2.19537493 |
| 196 | nucleobase biosynthetic process (GO:0046112) | 2.19152469 |
| 197 | cellular protein complex disassembly (GO:0043624) | 2.18864942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.23424929 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.94379795 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04549358 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02985110 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00122490 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91798291 |
| 7 | * MYC_22102868_ChIP-Seq_BL_Human | 2.85705282 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.66467067 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41708387 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40617226 |
| 11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.35414542 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33056307 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19824530 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19351556 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18295564 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10586166 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.10130169 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06362947 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06244788 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05649795 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.03032314 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99706336 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97639923 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96422033 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.94516952 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.91284162 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88192124 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.84012030 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83854538 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83618319 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.81787646 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81329837 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77852292 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.77618297 |
| 35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.75298674 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68187899 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.68047556 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66503569 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65235904 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.63237701 |
| 41 | * MYB_26560356_Chip-Seq_TH1_Human | 1.61955631 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61502820 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61313507 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.60803892 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59768901 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.59513822 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58730888 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58556621 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58343287 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58242771 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56691128 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.56285514 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56267864 |
| 54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54869705 |
| 55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51679033 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48712186 |
| 57 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.47923921 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47812519 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47272436 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44557673 |
| 61 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43994356 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43907920 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42780149 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42277252 |
| 65 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41960275 |
| 66 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41073699 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40773739 |
| 68 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40726349 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39071392 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38867760 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38640325 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36952855 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36424335 |
| 74 | * P68_20966046_ChIP-Seq_HELA_Human | 1.35176537 |
| 75 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.34636625 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32690290 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32609532 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32262230 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31207393 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31040428 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31020022 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30896109 |
| 83 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.29780203 |
| 84 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.29780203 |
| 85 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.29780203 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29224526 |
| 87 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29031519 |
| 88 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28493870 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28116988 |
| 90 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27841989 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.27622137 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27296319 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26516994 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26298738 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25867123 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24367454 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23785345 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23430666 |
| 99 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.23289436 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22104136 |
| 101 | * MAF_26560356_Chip-Seq_TH2_Human | 1.21642499 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21327758 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20859100 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20784089 |
| 105 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20186450 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18565257 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18527237 |
| 108 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18401244 |
| 109 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.17327419 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17073805 |
| 111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16398319 |
| 112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15659029 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15482664 |
| 114 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14825907 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14758857 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14527579 |
| 117 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14469151 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13032032 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12826616 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11252668 |
| 121 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10358661 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10169588 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09277985 |
| 124 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08534201 |
| 125 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08020565 |
| 126 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.08004596 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07279480 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05968150 |
| 129 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.05900590 |
| 130 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05461890 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04477292 |
| 132 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04403042 |
| 133 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04312576 |
| 134 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04167294 |
| 135 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.02783662 |
| 136 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02490816 |
| 137 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01473196 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01209349 |
| 139 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01065958 |
| 140 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99939060 |
| 141 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99929668 |
| 142 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99848231 |
| 143 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99763640 |
| 144 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99070572 |
| 145 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98799581 |
| 146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96724878 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96434129 |
| 148 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96220171 |
| 149 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.96156328 |
| 150 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.95416770 |
| 151 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95305823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.57213888 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.48470676 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.30457587 |
| 4 | MP0003195_calcinosis | 2.93885039 |
| 5 | MP0005451_abnormal_body_composition | 2.85711992 |
| 6 | MP0005671_abnormal_response_to | 2.67712312 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.66371570 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.63565812 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.54803795 |
| 10 | MP0000685_abnormal_immune_system | 2.53233130 |
| 11 | MP0003436_decreased_susceptibility_to | 2.48597404 |
| 12 | MP0001800_abnormal_humoral_immune | 2.44182857 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.43967173 |
| 14 | MP0009785_altered_susceptibility_to | 2.32529745 |
| 15 | MP0008057_abnormal_DNA_replication | 2.32152603 |
| 16 | MP0000490_abnormal_crypts_of | 2.27373925 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.19884961 |
| 18 | MP0002398_abnormal_bone_marrow | 2.18848136 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.10332332 |
| 20 | MP0001790_abnormal_immune_system | 2.08752028 |
| 21 | MP0005387_immune_system_phenotype | 2.08752028 |
| 22 | MP0001819_abnormal_immune_cell | 2.07472044 |
| 23 | MP0005025_abnormal_response_to | 2.06575834 |
| 24 | MP0002723_abnormal_immune_serum | 2.03616473 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.03001834 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.98235506 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.97850775 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 1.95434541 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.95211933 |
| 30 | MP0004957_abnormal_blastocyst_morpholog | 1.94998556 |
| 31 | MP0003866_abnormal_defecation | 1.92893855 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.92411800 |
| 33 | MP0003122_maternal_imprinting | 1.87793906 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.87640588 |
| 35 | MP0000716_abnormal_immune_system | 1.87492071 |
| 36 | MP0002722_abnormal_immune_system | 1.87107834 |
| 37 | MP0002405_respiratory_system_inflammati | 1.84862136 |
| 38 | MP0001873_stomach_inflammation | 1.83954457 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.82808729 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.78767226 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.74014761 |
| 42 | MP0002429_abnormal_blood_cell | 1.70655911 |
| 43 | MP0002419_abnormal_innate_immunity | 1.67328039 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.63969668 |
| 45 | MP0002006_tumorigenesis | 1.62108990 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.59602595 |
| 47 | MP0005365_abnormal_bile_salt | 1.55014806 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.54883240 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.54865247 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.50780600 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.50780600 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.49632686 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.48765022 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.47827761 |
| 55 | MP0003077_abnormal_cell_cycle | 1.44987911 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.44358162 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.40068404 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.37900392 |
| 59 | MP0008007_abnormal_cellular_replicative | 1.37270956 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.35305923 |
| 61 | MP0003111_abnormal_nucleus_morphology | 1.34969444 |
| 62 | MP0000858_altered_metastatic_potential | 1.34571706 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.32239546 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.30699852 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.30582851 |
| 66 | MP0001915_intracranial_hemorrhage | 1.30580934 |
| 67 | MP0008260_abnormal_autophagy | 1.29245192 |
| 68 | MP0001853_heart_inflammation | 1.28786244 |
| 69 | MP0000604_amyloidosis | 1.28565330 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.28172488 |
| 71 | MP0008058_abnormal_DNA_repair | 1.27719002 |
| 72 | MP0006082_CNS_inflammation | 1.23307680 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 1.19441602 |
| 74 | MP0008469_abnormal_protein_level | 1.18106207 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.15445975 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.14779302 |
| 77 | MP0009278_abnormal_bone_marrow | 1.14681573 |
| 78 | MP0000566_synostosis | 1.14356675 |
| 79 | MP0003724_increased_susceptibility_to | 1.13197088 |
| 80 | MP0004947_skin_inflammation | 1.10853683 |
| 81 | MP0005332_abnormal_amino_acid | 1.10286777 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 1.09757992 |
| 83 | MP0001764_abnormal_homeostasis | 1.09266494 |
| 84 | MP0001666_abnormal_nutrient_absorption | 1.07810599 |
| 85 | MP0003786_premature_aging | 1.07761800 |
| 86 | MP0002933_joint_inflammation | 1.07521768 |
| 87 | MP0000477_abnormal_intestine_morphology | 1.06775588 |
| 88 | MP0006054_spinal_hemorrhage | 1.02326222 |
| 89 | MP0002693_abnormal_pancreas_physiology | 1.01394236 |
| 90 | MP0003303_peritoneal_inflammation | 1.01284301 |
| 91 | MP0000609_abnormal_liver_physiology | 0.98195513 |
| 92 | MP0003075_altered_response_to | 0.95264089 |
| 93 | MP0003123_paternal_imprinting | 0.94148662 |
| 94 | MP0000313_abnormal_cell_death | 0.93359092 |
| 95 | MP0000350_abnormal_cell_proliferation | 0.92240619 |
| 96 | MP0003868_abnormal_feces_composition | 0.92044835 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.89891506 |
| 98 | MP0002928_abnormal_bile_duct | 0.89645872 |
| 99 | MP0005409_darkened_coat_color | 0.89567114 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.89294206 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.89120416 |
| 102 | MP0005670_abnormal_white_adipose | 0.87873415 |
| 103 | MP0010368_abnormal_lymphatic_system | 0.85949419 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.85548948 |
| 105 | MP0009642_abnormal_blood_homeostasis | 0.85546130 |
| 106 | MP0010307_abnormal_tumor_latency | 0.84991464 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.84359015 |
| 108 | MP0002132_abnormal_respiratory_system | 0.84296506 |
| 109 | MP0003283_abnormal_digestive_organ | 0.84278332 |
| 110 | MP0000598_abnormal_liver_morphology | 0.84182226 |
| 111 | MP0009840_abnormal_foam_cell | 0.83064083 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.82711870 |
| 113 | MP0003186_abnormal_redox_activity | 0.82488068 |
| 114 | MP0005310_abnormal_salivary_gland | 0.81850007 |
| 115 | MP0000371_diluted_coat_color | 0.81042897 |
| 116 | MP0005164_abnormal_response_to | 0.80738260 |
| 117 | MP0008438_abnormal_cutaneous_collagen | 0.79645587 |
| 118 | MP0005023_abnormal_wound_healing | 0.79243758 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.78926561 |
| 120 | MP0001661_extended_life_span | 0.76806183 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.76414351 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.76257795 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75823488 |
| 124 | MP0009763_increased_sensitivity_to | 0.75741332 |
| 125 | MP0005408_hypopigmentation | 0.74217828 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.72910456 |
| 127 | MP0000249_abnormal_blood_vessel | 0.71736558 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.71701722 |
| 129 | MP0003252_abnormal_bile_duct | 0.71382715 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.68081736 |
| 131 | MP0001663_abnormal_digestive_system | 0.67221327 |
| 132 | MP0009115_abnormal_fat_cell | 0.67145326 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.66462775 |
| 134 | MP0002971_abnormal_brown_adipose | 0.65999079 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.64452673 |
| 136 | MP0003448_altered_tumor_morphology | 0.64050602 |
| 137 | MP0002970_abnormal_white_adipose | 0.63820046 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.63680980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 8.68074422 |
| 2 | Joint hemorrhage (HP:0005261) | 5.93635359 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.65549157 |
| 4 | Complement deficiency (HP:0004431) | 5.36395482 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.63153768 |
| 6 | Abnormality of complement system (HP:0005339) | 4.52050676 |
| 7 | Hemorrhage of the eye (HP:0011885) | 4.38131532 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.28330279 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.23217576 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.15234586 |
| 11 | Xanthomatosis (HP:0000991) | 4.04440735 |
| 12 | IgM deficiency (HP:0002850) | 3.91347849 |
| 13 | Glomerulonephritis (HP:0000099) | 3.70309341 |
| 14 | T lymphocytopenia (HP:0005403) | 3.68514965 |
| 15 | Menorrhagia (HP:0000132) | 3.54165659 |
| 16 | Abnormality of T cells (HP:0002843) | 3.52283348 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.51660055 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.45286148 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.43622571 |
| 20 | Purpura (HP:0000979) | 3.43078686 |
| 21 | Hypercholesterolemia (HP:0003124) | 3.42465930 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.32746213 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.32293804 |
| 24 | Thrombocytosis (HP:0001894) | 3.31181008 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.19844058 |
| 26 | Chronic otitis media (HP:0000389) | 3.15721432 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13354528 |
| 28 | Abnormality of the lumbar spine (HP:0100712) | 3.06711312 |
| 29 | Recurrent viral infections (HP:0004429) | 3.03128995 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.99975643 |
| 31 | Pustule (HP:0200039) | 2.98045727 |
| 32 | Combined immunodeficiency (HP:0005387) | 2.96893250 |
| 33 | Spontaneous abortion (HP:0005268) | 2.91659286 |
| 34 | Nasal polyposis (HP:0100582) | 2.89445599 |
| 35 | Petechiae (HP:0000967) | 2.85687333 |
| 36 | Thrombophlebitis (HP:0004418) | 2.79587777 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.78185970 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.77864697 |
| 39 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.77148712 |
| 40 | Myositis (HP:0100614) | 2.74255313 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72497840 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72497840 |
| 43 | Chronic diarrhea (HP:0002028) | 2.71981377 |
| 44 | Type I transferrin isoform profile (HP:0003642) | 2.71159047 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.69050662 |
| 46 | Abnormal number of erythroid precursors (HP:0012131) | 2.67332232 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.66238216 |
| 48 | Poikiloderma (HP:0001029) | 2.62438078 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.61784728 |
| 50 | Myocardial infarction (HP:0001658) | 2.59724669 |
| 51 | Basal cell carcinoma (HP:0002671) | 2.57989089 |
| 52 | Hypoplasia of the thymus (HP:0000778) | 2.57750887 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.49458712 |
| 54 | Abnormality of carpal bone ossification (HP:0006257) | 2.49258340 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.48235288 |
| 56 | Hyperlipoproteinemia (HP:0010980) | 2.48006171 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47607487 |
| 58 | Aplastic anemia (HP:0001915) | 2.47591168 |
| 59 | Meningitis (HP:0001287) | 2.47554223 |
| 60 | Abnormality of the nasal mucosa (HP:0000433) | 2.46724893 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.44166759 |
| 62 | Small epiphyses (HP:0010585) | 2.40095352 |
| 63 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.38793988 |
| 64 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.38793988 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 2.38793988 |
| 66 | Abnormal glycosylation (HP:0012345) | 2.38793988 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38737563 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38737563 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38737563 |
| 70 | Reticulocytopenia (HP:0001896) | 2.38328862 |
| 71 | Flat acetabular roof (HP:0003180) | 2.34334182 |
| 72 | Multiple enchondromatosis (HP:0005701) | 2.34104806 |
| 73 | Lymphoma (HP:0002665) | 2.32982239 |
| 74 | IgG deficiency (HP:0004315) | 2.32057826 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27504741 |
| 76 | Recurrent skin infections (HP:0001581) | 2.27031760 |
| 77 | Cheilitis (HP:0100825) | 2.26877547 |
| 78 | Ependymoma (HP:0002888) | 2.26497368 |
| 79 | Increased serum ferritin (HP:0003281) | 2.26482412 |
| 80 | Stomatitis (HP:0010280) | 2.25837762 |
| 81 | Pulmonary embolism (HP:0002204) | 2.25442723 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.24532327 |
| 83 | Lymphopenia (HP:0001888) | 2.22685337 |
| 84 | Thyroiditis (HP:0100646) | 2.21673101 |
| 85 | Epistaxis (HP:0000421) | 2.21601939 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.19709038 |
| 87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19523600 |
| 88 | Asymmetry of the thorax (HP:0001555) | 2.18200930 |
| 89 | Cellulitis (HP:0100658) | 2.17513621 |
| 90 | Nephritis (HP:0000123) | 2.17513137 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 2.17188852 |
| 92 | Epiphyseal dysplasia (HP:0002656) | 2.14912469 |
| 93 | Agnosia (HP:0010524) | 2.14038916 |
| 94 | Hypochromic anemia (HP:0001931) | 2.13617803 |
| 95 | Hypertriglyceridemia (HP:0002155) | 2.13234122 |
| 96 | Abnormality of the thoracic spine (HP:0100711) | 2.12959097 |
| 97 | Acute lymphatic leukemia (HP:0006721) | 2.11985218 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.11520354 |
| 99 | 11 pairs of ribs (HP:0000878) | 2.11185456 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 2.09494671 |
| 101 | Protrusio acetabuli (HP:0003179) | 2.09480552 |
| 102 | Recurrent sinusitis (HP:0011108) | 2.09005623 |
| 103 | Hypoglycemic coma (HP:0001325) | 2.07973465 |
| 104 | Vascular calcification (HP:0004934) | 2.07680551 |
| 105 | Impaired platelet aggregation (HP:0003540) | 2.07665445 |
| 106 | Abnormal platelet function (HP:0011869) | 2.07665445 |
| 107 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06038922 |
| 108 | Amyloidosis (HP:0011034) | 2.05219145 |
| 109 | Bronchitis (HP:0012387) | 2.02872852 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02328675 |
| 111 | Leukocytosis (HP:0001974) | 2.01665647 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 2.01485033 |
| 113 | Obstructive lung disease (HP:0006536) | 2.00741159 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00741159 |
| 115 | Flared iliac wings (HP:0002869) | 1.97658868 |
| 116 | Abnormality of B cell number (HP:0010975) | 1.97444028 |
| 117 | B lymphocytopenia (HP:0010976) | 1.97444028 |
| 118 | Polygenic inheritance (HP:0010982) | 1.96556808 |
| 119 | Periodontitis (HP:0000704) | 1.95691883 |
| 120 | Gingival bleeding (HP:0000225) | 1.95684932 |
| 121 | Intestinal fistula (HP:0100819) | 1.94789330 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.94567319 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94567319 |
| 124 | Vacuolated lymphocytes (HP:0001922) | 1.93358356 |
| 125 | Hepatocellular carcinoma (HP:0001402) | 1.93248771 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92755504 |
| 127 | Myelodysplasia (HP:0002863) | 1.92741404 |
| 128 | Amaurosis fugax (HP:0100576) | 1.92414272 |
| 129 | Abnormality of eosinophils (HP:0001879) | 1.91670456 |
| 130 | Abnormal ossification of hand bones (HP:0005921) | 1.91493628 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.90679406 |
| 132 | Abnormality of the anterior horn cell (HP:0006802) | 1.90562116 |
| 133 | Degeneration of anterior horn cells (HP:0002398) | 1.90562116 |
| 134 | Colitis (HP:0002583) | 1.89296085 |
| 135 | Acanthocytosis (HP:0001927) | 1.86121570 |
| 136 | Abnormal tarsal ossification (HP:0008369) | 1.85830628 |
| 137 | Gingivitis (HP:0000230) | 1.85572875 |
| 138 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.85537527 |
| 139 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.85537527 |
| 140 | Broad alveolar ridges (HP:0000187) | 1.85437112 |
| 141 | Abnormality of macrophages (HP:0004311) | 1.85001566 |
| 142 | Microcytic anemia (HP:0001935) | 1.83923365 |
| 143 | Orchitis (HP:0100796) | 1.83912439 |
| 144 | Cardiovascular calcification (HP:0011915) | 1.81457954 |
| 145 | Abnormality of the fingertips (HP:0001211) | 1.80982121 |
| 146 | Granulocytopenia (HP:0001913) | 1.80807395 |
| 147 | Abnormality of the prostate (HP:0008775) | 1.80724135 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.80539518 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.80524787 |
| 150 | Progressive muscle weakness (HP:0003323) | 1.78278897 |
| 151 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.78206768 |
| 152 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77789555 |
| 153 | Hypergammaglobulinemia (HP:0010702) | 1.76705412 |
| 154 | Vasculitis (HP:0002633) | 1.76533892 |
| 155 | Pallor (HP:0000980) | 1.76144523 |
| 156 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.76060665 |
| 157 | Broad palm (HP:0001169) | 1.75754929 |
| 158 | Dysostosis multiplex (HP:0000943) | 1.75420368 |
| 159 | Vaginal fistula (HP:0004320) | 1.74410543 |
| 160 | Intrahepatic cholestasis (HP:0001406) | 1.74349421 |
| 161 | Gangrene (HP:0100758) | 1.73951897 |
| 162 | Seborrheic dermatitis (HP:0001051) | 1.72223531 |
| 163 | Biconcave vertebral bodies (HP:0004586) | 1.70650319 |
| 164 | J-shaped sella turcica (HP:0002680) | 1.70147182 |
| 165 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.69840392 |
| 166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67225083 |
| 167 | Arterial thrombosis (HP:0004420) | 1.66858607 |
| 168 | Enlarged kidneys (HP:0000105) | 1.66834108 |
| 169 | Gastrointestinal infarctions (HP:0005244) | 1.66682055 |
| 170 | Abnormal hand bone ossification (HP:0010660) | 1.66383037 |
| 171 | Mitral stenosis (HP:0001718) | 1.66153045 |
| 172 | Vertebral compression fractures (HP:0002953) | 1.65850446 |
| 173 | Cholecystitis (HP:0001082) | 1.65635356 |
| 174 | Abnormal gallbladder physiology (HP:0012438) | 1.65635356 |
| 175 | Abnormality of the acetabulum (HP:0003170) | 1.62414631 |
| 176 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.60318515 |
| 177 | Peritonitis (HP:0002586) | 1.58946913 |
| 178 | Abnormality of the pleura (HP:0002103) | 1.58831506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.37030226 |
| 2 | FLT3 | 4.05803588 |
| 3 | ERN1 | 2.95860770 |
| 4 | TXK | 2.89541964 |
| 5 | TRIB3 | 2.78413113 |
| 6 | ICK | 2.63671820 |
| 7 | NME2 | 2.62890431 |
| 8 | KIT | 2.39176496 |
| 9 | ZAP70 | 2.26036878 |
| 10 | STK10 | 2.17472171 |
| 11 | SMG1 | 2.16738471 |
| 12 | TEC | 2.16216394 |
| 13 | PRPF4B | 2.03695848 |
| 14 | PASK | 2.00688129 |
| 15 | GRK6 | 1.95217009 |
| 16 | CDK12 | 1.94956253 |
| 17 | CSF1R | 1.91968117 |
| 18 | EEF2K | 1.86983825 |
| 19 | BTK | 1.79851740 |
| 20 | JAK3 | 1.79047137 |
| 21 | IRAK4 | 1.75002106 |
| 22 | EIF2AK3 | 1.70081212 |
| 23 | TYK2 | 1.69221622 |
| 24 | ITK | 1.53917598 |
| 25 | TAOK3 | 1.53268726 |
| 26 | MAP3K10 | 1.52196406 |
| 27 | RIPK4 | 1.49658626 |
| 28 | PKN2 | 1.49300219 |
| 29 | IKBKE | 1.48171098 |
| 30 | MAP2K3 | 1.47121013 |
| 31 | BLK | 1.44988450 |
| 32 | MAP3K13 | 1.44916601 |
| 33 | RPS6KB2 | 1.38761978 |
| 34 | PIM1 | 1.33735228 |
| 35 | CSK | 1.30524808 |
| 36 | KDR | 1.30461681 |
| 37 | SIK2 | 1.26277924 |
| 38 | SYK | 1.25816162 |
| 39 | PIM2 | 1.23664908 |
| 40 | PDGFRA | 1.22262990 |
| 41 | LCK | 1.21001547 |
| 42 | ACVR1B | 1.20863947 |
| 43 | BCKDK | 1.15319985 |
| 44 | NLK | 1.14303892 |
| 45 | CDK7 | 1.12328814 |
| 46 | CDC42BPA | 1.11904885 |
| 47 | MAP3K14 | 1.08199517 |
| 48 | CDK4 | 1.07304443 |
| 49 | DDR2 | 1.06196949 |
| 50 | TBK1 | 1.04366710 |
| 51 | WNK4 | 1.03037119 |
| 52 | IKBKB | 0.99854439 |
| 53 | FGFR4 | 0.98821630 |
| 54 | MAP3K7 | 0.98787072 |
| 55 | PDPK1 | 0.98734276 |
| 56 | MST4 | 0.94296708 |
| 57 | LYN | 0.91525684 |
| 58 | HIPK2 | 0.90704578 |
| 59 | IRAK3 | 0.89703482 |
| 60 | MAPKAPK3 | 0.88094319 |
| 61 | MAP3K1 | 0.86463316 |
| 62 | RIPK1 | 0.84675191 |
| 63 | TGFBR1 | 0.84287443 |
| 64 | HCK | 0.83959435 |
| 65 | LRRK2 | 0.83019466 |
| 66 | TGFBR2 | 0.82822451 |
| 67 | PDK1 | 0.82718855 |
| 68 | ATR | 0.82569784 |
| 69 | TESK2 | 0.82397025 |
| 70 | FGR | 0.81969756 |
| 71 | DYRK3 | 0.81643148 |
| 72 | SCYL2 | 0.79658324 |
| 73 | MAP3K11 | 0.78391138 |
| 74 | MAPK15 | 0.77935661 |
| 75 | MAPK11 | 0.76515775 |
| 76 | EIF2AK1 | 0.75744476 |
| 77 | NEK2 | 0.75042665 |
| 78 | CDC7 | 0.74920155 |
| 79 | RPS6KA4 | 0.74644798 |
| 80 | TYRO3 | 0.73576573 |
| 81 | TNK2 | 0.72311028 |
| 82 | MAP3K8 | 0.72288716 |
| 83 | MAP3K3 | 0.72156643 |
| 84 | MAP2K6 | 0.70142228 |
| 85 | MATK | 0.69905879 |
| 86 | MAP2K2 | 0.68733056 |
| 87 | EPHA2 | 0.67905141 |
| 88 | PRKD2 | 0.67071211 |
| 89 | JAK1 | 0.66100015 |
| 90 | MAP3K6 | 0.64925673 |
| 91 | PRKAA2 | 0.63937012 |
| 92 | MTOR | 0.63234435 |
| 93 | STK16 | 0.62284829 |
| 94 | CHUK | 0.60515304 |
| 95 | CDK6 | 0.60115361 |
| 96 | CLK1 | 0.59851823 |
| 97 | RET | 0.58883628 |
| 98 | WEE1 | 0.58312227 |
| 99 | FGFR3 | 0.55401767 |
| 100 | CDK9 | 0.54378103 |
| 101 | JAK2 | 0.53952954 |
| 102 | FGFR1 | 0.53873254 |
| 103 | BMX | 0.53721954 |
| 104 | ARAF | 0.53682072 |
| 105 | TAOK1 | 0.51359989 |
| 106 | VRK1 | 0.50460469 |
| 107 | PRKG2 | 0.49196766 |
| 108 | NEK9 | 0.49026396 |
| 109 | TAOK2 | 0.48662486 |
| 110 | DAPK1 | 0.48415014 |
| 111 | WNK1 | 0.46868368 |
| 112 | CDK8 | 0.46631499 |
| 113 | MARK3 | 0.46330251 |
| 114 | INSRR | 0.46142406 |
| 115 | VRK2 | 0.46002334 |
| 116 | RPS6KA6 | 0.45959121 |
| 117 | MARK2 | 0.45938354 |
| 118 | SIK1 | 0.45842609 |
| 119 | STK4 | 0.45167679 |
| 120 | PTK6 | 0.43833875 |
| 121 | RPS6KC1 | 0.42692015 |
| 122 | RPS6KL1 | 0.42692015 |
| 123 | ALK | 0.42627929 |
| 124 | MAPKAPK2 | 0.42372078 |
| 125 | ADRBK2 | 0.41892996 |
| 126 | FES | 0.40819988 |
| 127 | MAP3K5 | 0.40764670 |
| 128 | AURKB | 0.40638634 |
| 129 | MST1R | 0.39590167 |
| 130 | MAPK4 | 0.39346987 |
| 131 | PAK4 | 0.38905194 |
| 132 | MAPK12 | 0.38832152 |
| 133 | DYRK1B | 0.36466028 |
| 134 | MAPK3 | 0.36343273 |
| 135 | PLK1 | 0.35346937 |
| 136 | NUAK1 | 0.34802976 |
| 137 | PIK3CA | 0.32772203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.59620202 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.47094670 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.30311861 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.24642647 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.78649282 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.42403114 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.17133438 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06795818 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.96796317 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 1.91692094 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90248929 |
| 12 | Protein export_Homo sapiens_hsa03060 | 1.84193379 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79656027 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79407429 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76355787 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75533204 |
| 17 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.72821025 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.70904036 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70282153 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69794322 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.63697703 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59561471 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.59415797 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.55810766 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.51613086 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51155481 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.50089454 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49694159 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46998915 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46217194 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.46000579 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44893253 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44862395 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43236536 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41174719 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40443901 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36515953 |
| 38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36501387 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34503746 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30338958 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28914441 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28432315 |
| 43 | RNA polymerase_Homo sapiens_hsa03020 | 1.24426078 |
| 44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.22912546 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.21899977 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.21647356 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21363531 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.20789854 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20596546 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18956745 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16993008 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12456351 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11225603 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.10113626 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09747935 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.04846290 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04265309 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02499439 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01773547 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01453794 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01364485 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.01011121 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00832898 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98438925 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.98185196 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96579614 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95518345 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.94990693 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91588765 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90468054 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89819905 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89750729 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89068231 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87741712 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86095795 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85980052 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84938716 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.84659014 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84469811 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82149457 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81828069 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.81716244 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81129432 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80949854 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.80809553 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79954878 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79717668 |
| 88 | Proteasome_Homo sapiens_hsa03050 | 0.79532231 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79363614 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78701699 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76572253 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.75928892 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75674122 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73673058 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73449566 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69674512 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.69549224 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67416368 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66841644 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64300923 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63974975 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.63122587 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63052998 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62196295 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61974606 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60530215 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58189827 |
| 108 | Peroxisome_Homo sapiens_hsa04146 | 0.57967322 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.56044220 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55961630 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55756836 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55671850 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55469738 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55203902 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55111121 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51838401 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51685340 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51400636 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.50825149 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50624242 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50032114 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.49880565 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48685546 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48633701 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.48316398 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.46465948 |
| 127 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46218459 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45816820 |
| 129 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45450801 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45105559 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.44434461 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43957044 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.43216121 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42221435 |
| 135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41685317 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41466758 |
| 137 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40726698 |
| 138 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40524768 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40246950 |
| 140 | Lysine degradation_Homo sapiens_hsa00310 | 0.37951979 |
| 141 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37341550 |
| 142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36151803 |
| 143 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35985463 |
| 144 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35481743 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34903917 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34587728 |
| 147 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33710180 |
| 148 | Lysosome_Homo sapiens_hsa04142 | 0.33405546 |
| 149 | Hepatitis C_Homo sapiens_hsa05160 | 0.33009944 |

